134 related articles for article (PubMed ID: 28938952)
1. APOL1 and blood pressure changes in young adults.
Nadkarni GN; Coca SG
Kidney Int; 2017 Oct; 92(4):793-795. PubMed ID: 28938952
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
Nadkarni GN; Galarneau G; Ellis SB; Nadukuru R; Zhang J; Scott SA; Schurmann C; Li R; Rasmussen-Torvik LJ; Kho AN; Hayes MG; Pacheco JA; Manolio TA; Chisholm RL; Roden DM; Denny JC; Kenny EE; Bottinger EP
J Am Coll Cardiol; 2017 Mar; 69(12):1564-1574. PubMed ID: 28335839
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
4.
Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
[TBL] [Abstract][Full Text] [Related]
5. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
[TBL] [Abstract][Full Text] [Related]
6. "Biomarking" the transition from genetic risk to kidney disease.
Kruzel-Davila E; Skorecki K
Kidney Int; 2018 Jun; 93(6):1270-1272. PubMed ID: 29792270
[TBL] [Abstract][Full Text] [Related]
7. Should kidney donors be genotyped for APOL1 risk alleles?
Freedman BI; Julian BA
Kidney Int; 2015 Apr; 87(4):671-3. PubMed ID: 25826538
[No Abstract] [Full Text] [Related]
8. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
[TBL] [Abstract][Full Text] [Related]
9. African American living-kidney donors should be screened for APOL1 risk alleles.
Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein L1 and Kidney Disease in African Americans.
Friedman DJ; Pollak MR
Trends Endocrinol Metab; 2016 Apr; 27(4):204-215. PubMed ID: 26947522
[TBL] [Abstract][Full Text] [Related]
11. The Apolipoprotein L1 Gene and Cardiovascular Disease.
Robinson TW; Freedman BI
Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
[TBL] [Abstract][Full Text] [Related]
12. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy.
Larsen CP; Beggs ML; Walker PD; Saeed M; Ambruzs JM; Messias NC
Am J Kidney Dis; 2014 Jul; 64(1):161-3. PubMed ID: 24731740
[No Abstract] [Full Text] [Related]
14. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
Riella LV; Sheridan AM
Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
[TBL] [Abstract][Full Text] [Related]
15. Determining the effects and challenges of incorporating genetic testing into primary care management of hypertensive patients with African ancestry.
Horowitz CR; Abul-Husn NS; Ellis S; Ramos MA; Negron R; Suprun M; Zinberg RE; Sabin T; Hauser D; Calman N; Bagiella E; Bottinger EP
Contemp Clin Trials; 2016 Mar; 47():101-8. PubMed ID: 26747051
[TBL] [Abstract][Full Text] [Related]
16. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
Tzur S; Rosset S; Skorecki K; Wasser WG
Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
[TBL] [Abstract][Full Text] [Related]
17. APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.
McLean NO; Robinson TW; Freedman BI
Am J Kidney Dis; 2017 Aug; 70(2):281-289. PubMed ID: 28143671
[TBL] [Abstract][Full Text] [Related]
18. APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
[TBL] [Abstract][Full Text] [Related]
19. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
[TBL] [Abstract][Full Text] [Related]
20. APOL1 genotype, blood pressure, and survival in African Americans with nondiabetic nephropathy.
Robinson TW; Freedman BI
Kidney Int; 2017 Feb; 91(2):276-278. PubMed ID: 28087008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
